A Derivate of the Antibiotic Doxorubicin Inhibits Dengue and Yellow Fever Virus Replication In Vitro

Suzanne J. F. Kaptein; Michael Jacobs; Andrea V. Gamarnik; De Clercq Erik; Ferenc Sztaricskai; Johan Neyts

doi:10.1016/j.antiviral.2008.01.058

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2006

The Anti-Yellow Fever Virus Activity of Ribavirin Is Independent of Error-Prone Replication

Pieter Leyssen, De Clercq Erik, Johan Neyts

Article1987

Phosphonylmethoxyalkylpurines and -pyrimidines as inhibitors of African swine fever virus replication in vitro

Carmen Gil-Fernández, Dolores García-Villalón, De Clercq Erik, Ivan Rosenberg, Antonı́n Holý

Article1996

Use of the yellow fever virus vaccine strain 17D for the study of strategies for the treatment of yellow fever virus infections

Johan Neyts, Astrid Meerbach, Paula McKenna, De Clercq Erik

Article2024

In‐host modeling of dengue virus and non‐structural protein 1 and the effects of ivermectin in patients with acute dengue fever

Junjie Ding, Dumrong Mairiang, Dararat Prayongkul, Chunya Puttikhunt, Sansanee Noisakran, Nattapong Kaewjiw, Adisak Songjaeng, Tanapan Prommool, Nattaya Tangthawornchaikul, Nasikarn Angkasekwinai, Yupin Suputtamongkol, Keswadee Lapphra, Kulkanya Chokephaibulkit, Sir Nicholas White, Panisadee Avirutnan, Joel Tärning

CPT Pharmacometrics & Systems Pharmacology

Article1987

Comparative efficacy of broad-spectrum antiviral agents as inhibitors of African swine fever virus replication in vitro

Carmen Gil-Fernández, De Clercq Erik